Investing

Merck : MRK

MRK

Stock Data

$128.57

$0.20 (0.16%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Merck & Co Inc is a global healthcare leader known for its innovative pharmaceuticals and animal health products. With a rich history dating back to 1891, Merck has made significant strides in oncology, immunology, neuroscience, and more, offering well-known brands like Keytruda and Januvia. Its pharmaceutical segment focuses on human health, while the Animal Health division provides veterinary pharmaceuticals and services. Merck collaborates with industry giants like AstraZeneca and Bayer, emphasizing its commitment to advancing healthcare across both human and animal sectors.

Latest Activity

MRKMerck & Co., Inc.

Reports Tue Aug 4Before open6:30 AM ETConfirmed

Aug 4, 5:00am ET

Merck reports before the open at 6:30 AM ET, and the line that matters is Keytruda: any guidance language on Medicare price negotiation exposure sets the tone for oncology peers like Pfizer and Bristol Myers Squibb. Confirmed date, so no surprises on timing.

ShareRead more

All Merck Articles

1096 Articles

Vandita Jadeja | Yesterday

After Q2 Earnings, Is Pfizer or Merck the Smarter Dividend Play?

Pfizer carries one of Big Pharma's fattest yields while Merck burns cash on deals to secure its next growth era.…

Vandita Jadeja | Aug 5, 2026 at 10:00 AM EDT

Prediction: AbbVie Will End The Year at This Price

AbbVie's blockbuster drugs are surging while a major acquisition looms, but a trailing P/E of 71 and one model pricing…

Ryne Mauck | Aug 3, 2026 at 11:45 PM EDT

SCHD’s 0.06% Fee Hides the Real Cost: How March Reconstitution Triggered $0.8241 Per Share in Surprise Distributions

SCHD charges just 0.06% per year, but taxable investors who lived through the March reconstitution discovered a second bill arriving…

Thomas Richmond | Aug 3, 2026 at 1:17 PM EDT

Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could “Cut Costs in a Big Way”

A Mizuho healthcare analyst says merging two of pharma's biggest names could unlock a fortune, but the math only works…

Thomas Richmond | Jul 28, 2026 at 1:09 PM EDT

3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st

AbbVie's two newest drugs are growing so fast they've rewritten the company's entire story, and Wall Street may not have…

David Beren | Jul 25, 2026 at 12:24 PM EDT

The 3.4% Income Play That Beats the Dogs of the Dow Strategy

Applying the Dogs of the Dow logic across the entire S&P 500 sounds like a recipe for chasing troubled dividends,…

Vandita Jadeja | Jul 24, 2026 at 1:30 PM EDT

This Catalyst Makes Eli Lilly a Top Growth Stock in 2026

Eli Lilly just won FDA clearance for an oral GLP-1 that targets over one billion potential patients worldwide, and the…

David Beren | Jul 23, 2026 at 11:27 AM EDT

Why Retirees Are Choosing This $100.8 Billion ETF Over Individual Dividend Stocks

SCHD's 100-stock structure and rock-bottom fees make it a retiree favorite, but a closer look at its top four holdings…

Trey Thoelcke | Jul 17, 2026 at 11:05 AM EDT

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

The FDA just approved the first once-daily oral PCSK9 pill, and five major stocks now sit in the crosshairs. Not…

Vandita Jadeja | Jul 15, 2026 at 1:29 PM EDT

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Johnson and Johnson has quietly become one of the best-performing mega-caps of the past year, but with a fresh pullback…

Vandita Jadeja | Jul 14, 2026 at 12:30 PM EDT

This Healthcare Giant Still Checks Every Box for Long-Term Investors

Johnson and Johnson just raised its full-year outlook toward a historic $100 billion revenue target, yet the stock still trades…

Vandita Jadeja | Jul 13, 2026 at 2:00 PM EDT

Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher

Eli Lilly has whipsawed shareholders in 2026, but one under-the-radar catalyst in its pipeline could change the trajectory entirely. Here…

John Seetoo | Jul 5, 2026 at 1:47 PM EDT

Six Dividend Aristocrats Keeping SCHD’s Income Stream Bulletproof This Year

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) pays a quarterly distribution from roughly 100 quality-screened U.S. dividend stocks. The fund holds…

David Moadel | Jun 26, 2026 at 12:01 PM EDT

Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending…

Lee Jackson | Jun 24, 2026 at 8:15 AM EDT

Here Are Wednesday’s Best Wall Street Analyst Research Calls: Devon Energy, Flowserve, Klaviyo, Macerich, Merck, Nucor, Take-Two Interactive Software, Twilio, and More

  Pre-Market Stock Futures: Futures are trading higher this morning, but if you’ve ever heard the old saying, “when the…